Comments
Loading...

Amgen

AMGNNASDAQ
Logo brought to you by Benzinga Data
$320.16
4.621.46%
At close: -
$318.07
-2.09-0.65%
After Hours: 7:06 PM EDT
15 minutes delayed
Q3 2024 Earnings were released on Wed Oct 30th, after the market close
The most recent conference call was at 16:30 PM, 1 day ago Click to view past webcast
Consensus Rating1
Outperform
Highest Price Target1
$405.00
Lowest Price Target1
$182.00
Consensus Price Target1
$308.07

Amgen (NASDAQ:AMGN) Stock, Analyst Ratings, Price Targets, Forecasts

Amgen Inc has a consensus price target of $308.07 based on the ratings of 31 analysts. The high is $405 issued by Cantor Fitzgerald on October 22, 2024. The low is $182 issued by Atlantic Equities on August 9, 2022. The 3 most-recent analyst ratings were released by UBS, Cantor Fitzgerald, and TD Cowen on October 31, 2024, October 22, 2024, and October 21, 2024, respectively. With an average price target of $371.33 between UBS, Cantor Fitzgerald, and TD Cowen, there's an implied 15.98% upside for Amgen Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
2
2
Aug
2
1
Sep
2
2
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
Cantor Fitzgerald
TD Cowen
Bernstein
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Amgen

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Amgen (AMGN) stock?

A

The latest price target for Amgen (NASDAQ:AMGN) was reported by UBS on October 31, 2024. The analyst firm set a price target for $326.00 expecting AMGN to rise to within 12 months (a possible 2.49% upside). 46 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Amgen (AMGN)?

A

The latest analyst rating for Amgen (NASDAQ:AMGN) was provided by UBS, and Amgen maintained their neutral rating.

Q

When was the last upgrade for Amgen (AMGN)?

A

The last upgrade for Amgen Inc happened on May 3, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Amgen Inc.

Q

When was the last downgrade for Amgen (AMGN)?

A

The last downgrade for Amgen Inc happened on October 14, 2024 when Truist Securities changed their price target from $320 to $333 for Amgen Inc.

Q

When is the next analyst rating going to be posted or updated for Amgen (AMGN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amgen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amgen was filed on October 31, 2024 so you should expect the next rating to be made available sometime around October 31, 2025.

Q

Is the Analyst Rating Amgen (AMGN) correct?

A

While ratings are subjective and will change, the latest Amgen (AMGN) rating was a maintained with a price target of $335.00 to $326.00. The current price Amgen (AMGN) is trading at is $318.07, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch